Oesophageal Cancer Research Review, Issue 6
In this issue:
LNR predicts adjuvant chemotherapy benefit in ESCC
KEYNOTE-585: No survival benefit to perioperative pembrolizumab
Mycobiome profiling may predict response to neoadjuvant immunochemotherapy
Encouraging activity for neoadjuvant immuno-chemo in locally advanced dMMR disease
Omission of nasogastric tube post-resection risks anastomotic leakage
Radiation dose escalation beneficial in select subgroups with locally advanced disease
Second-line T-DXd boosts survival in unresectable HER2-positive disease
CLDN18.2–targeting antibody–drug conjugate promising for advanced disease
High surgical conversion rate with neoadjuvant chemoradiation + immunotherapy for ESCC
First-in-class bispecific antibody-drug conjugate promising for pretreated ESCC
Expert contributor
Dr Annette Tognela
Dr Annette Tognela is a senior medical oncologist and Director of the Macarthur Cancer Therapy Centre, Campbelltown. She specialises in gastrointestinal, lung and brain cancers and also practices at GenesisCare, Campbelltown. Dr Tognela is a Conjoint Senior Lecturer at the Western Sydney University and is an investigator on gastrointestinal clinical trials.
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.